1![Estimation of glomerular filtration rate in dogs by plasma clearance of gadolinium diethylenetriamine pentaacetic acid as measured by use of an ELISA Benjamin G. Nolan, PhD, DVM; Linda A. Ross, DVM, MS; Dennis E. Vaccaro Estimation of glomerular filtration rate in dogs by plasma clearance of gadolinium diethylenetriamine pentaacetic acid as measured by use of an ELISA Benjamin G. Nolan, PhD, DVM; Linda A. Ross, DVM, MS; Dennis E. Vaccaro](https://www.pdfsearch.io/img/6072df62c5cf6cd34081022e100b0d3a.jpg) | Add to Reading ListSource URL: www.biopal.comLanguage: English - Date: 2015-01-16 16:22:31
|
---|
2![[removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION [removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION](https://www.pdfsearch.io/img/b7ed40de17a3cdfd331c3ac02e524cab.jpg) | Add to Reading ListSource URL: www.lantheus.comLanguage: English - Date: 2014-01-01 15:09:52
|
---|
3![MIAP1 2002 MEDICAL IMAGING ADVISORY PANEL 1 Study & Resource Guide MIAP1 2002 MEDICAL IMAGING ADVISORY PANEL 1 Study & Resource Guide](https://www.pdfsearch.io/img/5d7887066f3f24f9413fe17b28a8bd33.jpg) | Add to Reading ListSource URL: www.air.asn.auLanguage: English - Date: 2014-12-17 22:57:25
|
---|
4![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f](https://www.pdfsearch.io/img/de277852f2f77dbcf5fc13035345bbdc.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-11-17 14:53:23
|
---|
5![Omniscan (gadodiamide) injection label Omniscan (gadodiamide) injection label](https://www.pdfsearch.io/img/b5bbd043a0f088886517c3006d334a95.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-12-21 14:44:58
|
---|
6![Prohance (gadoteridol) injection label Prohance (gadoteridol) injection label](https://www.pdfsearch.io/img/2b6cf59e457c67454eedb23274725f5c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-12-21 14:29:00
|
---|
7![Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist](https://www.pdfsearch.io/img/c76d48747274a74e1332537007bb03c2.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-04-01 10:51:04
|
---|
8![Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc](https://www.pdfsearch.io/img/16e338216baf254c0dc2ad3a2f5b8916.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
9![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived](https://www.pdfsearch.io/img/8dc5ce18a10a698559638827b4891c63.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 of
AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 of](https://www.pdfsearch.io/img/344696d04fa922400866bffc210834d8.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|